Jacob Plieth — Robbin sends Battman packing, and here comes the Joker. @ApexOnco take on $AGEN (+95% currently) https://t.co/hOYw0Vdf7F↗
Jul 13
Martin Shkreli — short $AGEN - PIPE does not change bleak outlook. should trade back to PIPE price↗
Jul 13
Jacob Plieth — Any comment on this, @CDNCancerTrials? DMs are open $AGEN↗
Jul 13
Jacob Plieth — OK, $AGEN is "discontinuing financial support" for a study that's actively enrolling 834 patients. I'm sure that's ethically fine. Good luck to all involved! https://t.co/Ksv9kIcEw…↗
Jul 13
Martin Shkreli — lol who is buying $AGEN on a PIPE and warrants↗
Jul 13
Adam Feuerstein ✡️ — $AGEN BOT BAL pivot and new financing but without the departure of CEO Garo Armen seems self defeating.
How or why the new funders didn't demand he exit is puzzling.↗
November 2025 · 1 mention
Nov 7
Jacob Plieth — $URGN exits, and Garo Armen looks like a genius again. @ApexOnco on $AGEN's ill-fated deals: https://t.co/5RvkWTK1au $LGND https://t.co/9rjfgWl1bX↗
October 2025 · 1 mention
Oct 22
Jacob Plieth — Who won #ESMO25 and who lost? Via @ApexOnco
https://t.co/EWzHIIH1Ck
$IOBT $CELC $RCUS $CGEM $IDYA $NUVL $AGEN $GILD $DSNKY $INCY $CATX $LPTX $OLMA $SMMT $AVBP $GMAB $EXEL $CGEN $Z…↗
July 2025 · 5 mentions
Jul 14
Jacob Plieth — Intriguing case report nevertheless: stable disease for 800 days after AGENT-797 + Opdivo.
BTW $INKT still appears to be majority-owned by $AGEN.↗
Jul 14
Jacob Plieth — When is a complete response not actually a complete response? Ask $INKT. Via @ApexOnco -> https://t.co/t7quJGzPzh $AGEN↗
Jul 7
Jacob Plieth — Any ideas why $AGEN still hasn't said anything about survival from this phase 2 trial in MSS colorectal cancer? Dataset is now over a year old https://t.co/HgaAwdtfql↗
Jul 7
Jacob Plieth — ...because putting patients on bot monotherapy would have been unethical? $AGEN https://t.co/lVlTykZNY9